GPER1 and adrenal cortex carcinoma: Furthermore, GPER1 has been reported to inhibit tumor proliferation in colorectal, prostate, and adrenocortical carcinomas, and GPER agonists have demonstrated growth inhibition in ovarian cancer [15–18, 22].